Downloads: 1
| # | nr | Sample.ID | Patient.ID | Dataset | Treatment | Treatment_status | Chemo_status | Endo_status | Response_type | Response | Response_coded | Timepoint | Timepoint_coded | Platform | Platform_comp | scmod1 | pam50 | ClaudinLow | Mammaprint_risk | Mammaprint_score | rorS_risk | rorS_score | IC10 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 7462 | GSM465183 | XVC1.1 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Responder | 1 | On-treatment | T2 | GPL570 | Affymetrix | ER-/HER2- | LumA | Others | 1 | -0.162628113799854 | Intermediate | 30.4917585774848 | iC4 |
| 2 | 7510 | GSM465184 | XVC1.3 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Responder | 1 | Pre-treatment | T1 | GPL570 | Affymetrix | HER2+ | LumB | Others | 1 | -0.0889592760180995 | High | 62.739003577552 | iC5 |
| 3 | 7226 | GSM465186 | XVC1.4 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | Pre-treatment | T1 | GPL570 | Affymetrix | ER-/HER2- | Normal | Others | 1 | 0.258099547511312 | High | 56.5627583840895 | iC4 |
| 4 | 5525 | GSM465189 | XVC1.6 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Responder | 1 | On-treatment | T2 | GPL570 | Affymetrix | ER+/HER2- Low Prolif | LumA | Others | 0 | -0.467330316742081 | Intermediate | 44.8575200192419 | iC7 |
| 5 | 9290 | GSM465190 | XVC1.6 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Responder | 1 | Pre-treatment | T1 | GPL570 | Affymetrix | ER-/HER2- | LumB | Others | 1 | 0.0195492805579385 | High | 100.0 | iC4 |
| 6 | 7985 | GSM465191 | XVC1.7 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | Pre-treatment | T1 | GPL570 | Affymetrix | ER+/HER2- Low Prolif | LumA | Others | 0 | -0.521085972850679 | Intermediate | 45.799409285175 | iC8 |
| 7 | 6841 | GSM465194 | XVC1.8 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | Pre-treatment | T1 | GPL570 | Affymetrix | ER-/HER2- | Basal | Others | 1 | 0.306968325791855 | High | 82.2851302412254 | iC9 |
| 8 | 6141 | GSM465195 | XVC1.8 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | On-treatment | T2 | GPL570 | Affymetrix | ER-/HER2- | Basal | Others | 1 | 0.441719457013575 | High | 77.0324311389812 | iC9 |
| 9 | 8370 | GSM465198 | XVC1.12 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Responder | 1 | Pre-treatment | T1 | GPL570 | Affymetrix | ER+/HER2- High Prolif | LumB | Others | 1 | 0.350678733031674 | High | 82.722582202503 | iC1 |
| 10 | 8445 | GSM465199 | XVC1.12 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Responder | 1 | On-treatment | T2 | GPL570 | Affymetrix | ER+/HER2- Low Prolif | LumA | Others | 1 | -0.120452488687783 | Low | 24.2926920455174 | iC3 |
| 11 | 9760 | GSM465200 | XVC1.13 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | On-treatment | T2 | GPL570 | Affymetrix | ER-/HER2- | Normal | Others | 1 | -0.0657013574660633 | Intermediate | 36.2882677701904 | iC4 |
| 12 | 6626 | GSM465201 | XVC1.13 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | Pre-treatment | T1 | GPL570 | Affymetrix | ER-/HER2- | Basal | Others | 1 | 0.45131221719457 | High | 90.2362413666853 | iC10 |
| 13 | 7756 | GSM465203 | XVC1.14 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Responder | 1 | Pre-treatment | T1 | GPL570 | Affymetrix | HER2+ | Her2 | Others | 1 | 0.0180090497737557 | High | 79.9434274548732 | iC5 |
| 14 | 5952 | GSM465204 | XVC1.14 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Responder | 1 | On-treatment | T2 | GPL570 | Affymetrix | ER-/HER2- | LumA | Others | 1 | -0.237742935421377 | Intermediate | 42.2882833711557 | iC4 |
| 15 | 9443 | GSM465205 | XVC1.15 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | On-treatment | T2 | GPL570 | Affymetrix | HER2+ | LumA | Others | 1 | -0.0575617705317079 | Intermediate | 44.869803395167 | iC9 |
| 16 | 6016 | GSM465206 | XVC1.15 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | Pre-treatment | T1 | GPL570 | Affymetrix | HER2+ | LumB | Others | 1 | 0.0209049773755656 | High | 81.2395692824849 | iC9 |
| 17 | 7012 | GSM465209 | XVC1.16 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | Pre-treatment | T1 | GPL570 | Affymetrix | ER-/HER2- | Basal | Others | 1 | 0.501900452488688 | High | 97.5671238971029 | iC9 |
| 18 | 7887 | GSM465210 | XVC1.17 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | Pre-treatment | T1 | GPL570 | Affymetrix | ER-/HER2- | Normal | Others | 1 | -0.182443438914027 | Low | 25.8188793896265 | iC4 |
| 19 | 7566 | GSM465211 | XVC1.17 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | On-treatment | T2 | GPL570 | Affymetrix | ER-/HER2- | Basal | Others | 1 | 0.382361591989082 | High | 66.6703032930371 | iC9 |
| 20 | 6449 | GSM465213 | XVC1.18 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Responder | 1 | On-treatment | T2 | GPL570 | Affymetrix | ER-/HER2- | Normal | Others | 1 | -0.278859240886777 | Low | 0.0 | iC4 |
| 21 | 6789 | GSM465215 | XVC1.18 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Responder | 1 | Pre-treatment | T1 | GPL570 | Affymetrix | ER-/HER2- | Basal | Others | 1 | 0.538371040723982 | High | 61.6975370774532 | iC10 |
| 22 | 9306 | GSM465216 | XVC1.19 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | Pre-treatment | T1 | GPL570 | Affymetrix | ER+/HER2- Low Prolif | LumA | Others | 0 | -0.317918552036199 | Low | 3.02103523901115 | iC4 |
| 23 | 7979 | GSM465217 | XVC1.19 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | On-treatment | T2 | GPL570 | Affymetrix | ER+/HER2- High Prolif | Basal | Others | 1 | 0.155656108597285 | High | 55.1821069301135 | iC8 |
| 24 | 6613 | GSM465220 | XVC1.20 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | On-treatment | T2 | GPL570 | Affymetrix | ER-/HER2- | Basal | Others | 1 | 0.461990950226244 | High | 71.3494863226689 | iC10 |
| 25 | 5554 | GSM465221 | XVC1.20 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | Pre-treatment | T1 | GPL570 | Affymetrix | ER-/HER2- | Basal | Others | 1 | 0.449452440975568 | High | 98.8843931313057 | iC10 |
| 26 | 9468 | GSM465223 | XVC1.21 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Responder | 1 | Pre-treatment | T1 | GPL570 | Affymetrix | ER-/HER2- | Basal | Others | 1 | 0.425882352941176 | High | 69.1845003712918 | iC10 |
| 27 | 6166 | GSM465224 | XVC1.22 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Responder | 1 | On-treatment | T2 | GPL570 | Affymetrix | ER+/HER2- Low Prolif | LumA | Others | 1 | -0.203076923076923 | Low | 26.8243777128438 | iC4 |
| 28 | 7591 | GSM465226 | XVC1.23 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | On-treatment | T2 | GPL570 | Affymetrix | ER+/HER2- High Prolif | LumA | Others | 1 | -0.0930790289611293 | High | 56.8689340429284 | iC1 |
| 29 | 7537 | GSM465228 | XVC1.24 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | Pre-treatment | T1 | GPL570 | Affymetrix | ER-/HER2- | Basal | Others | 1 | 0.485972850678733 | High | 79.1136715985848 | iC3 |
| 30 | 6798 | GSM465230 | XVC1.25 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Responder | 1 | Pre-treatment | T1 | GPL570 | Affymetrix | ER+/HER2- High Prolif | LumB | Others | 1 | -0.104072398190045 | High | 60.1489247567359 | iC3 |
| 31 | 5904 | GSM465231 | XVC1.25 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Responder | 1 | On-treatment | T2 | GPL570 | Affymetrix | HER2+ | LumA | Others | 1 | -0.201990950226244 | Intermediate | 38.3605968249626 | iC3 |
| 32 | 6046 | GSM465233 | XVC1.26 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | Pre-treatment | T1 | GPL570 | Affymetrix | ER+/HER2- High Prolif | LumB | Others | 1 | -0.232760180995475 | High | 71.5928609443306 | iC3 |
| 33 | 8003 | GSM465234 | XVC1.26 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | On-treatment | T2 | GPL570 | Affymetrix | ER+/HER2- Low Prolif | LumA | Others | 1 | -0.211402714932127 | High | 61.8209805426826 | iC3 |
| 34 | 9404 | GSM465235 | XVC1.27 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Responder | 1 | Pre-treatment | T1 | GPL570 | Affymetrix | HER2+ | Her2 | Others | 1 | -0.0938546478638068 | High | 76.7746440229008 | iC5 |
| 35 | 8206 | GSM465236 | XVC1.27 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Responder | 1 | On-treatment | T2 | GPL570 | Affymetrix | HER2+ | LumA | Others | 1 | -0.21887373023091 | Intermediate | 30.0359072930354 | iC4 |
| 36 | 8994 | GSM465237 | XVC1.28 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | Pre-treatment | T1 | GPL570 | Affymetrix | ER+/HER2- Low Prolif | LumA | Others | 0 | -0.516618023164421 | Intermediate | 46.636480409881 | iC8 |
| 37 | 5165 | GSM465239 | XVC1.29 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | On-treatment | T2 | GPL570 | Affymetrix | ER-/HER2- | Her2 | Others | 1 | 0.0016289592760181 | High | 79.2672587653124 | iC4 |
| 38 | 5216 | GSM465240 | XVC1.29 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Non_responder | 0 | Pre-treatment | T1 | GPL570 | Affymetrix | ER-/HER2- | Basal | Others | 1 | 0.479638009049774 | High | 92.0283741107954 | iC5 |
| 39 | 6313 | GSM465242 | XVC1.30 | XVC1 | Chemotherapy | 1 | 1 | 0 | pCR & tumor size | Responder | 1 | On-treatment | T2 | GPL570 | Affymetrix | ER-/HER2- | Basal | Others | 1 | 0.220361990950226 | High | 76.9453958160056 | iC10 |
| 40 | 7628 | GSM3362421 | XVC2.1 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Claudin | 1 | 0.00862289763510629 | High | 90.7820786342675 | iC9 |
| 41 | 5587 | GSM3362422 | XVC2.1 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Claudin | 1 | 0.213438060274908 | High | 95.5580623695832 | iC9 |
| 42 | 6598 | GSM3362423 | XVC2.4 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Non_responder | 0 | 2 weeks | T2 | GPL6104 | Illumina | ER+/HER2- Low Prolif | Normal | Others | 0 | -0.450695808076496 | Low | 17.1352215727531 | iC7 |
| 43 | 9236 | GSM3362424 | XVC2.4 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Non_responder | 0 | 2 weeks | T2 | GPL6104 | Illumina | ER+/HER2- Low Prolif | Normal | Others | 0 | -0.477845129343465 | Low | 22.492548016051 | iC7 |
| 44 | 9817 | GSM3362425 | XVC2.4 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Non_responder | 0 | Pre-treatment | T1 | GPL6104 | Illumina | ER+/HER2- Low Prolif | LumA | Others | 0 | -0.531375394860412 | Low | 0.0 | iC7 |
| 45 | 8936 | GSM3362426 | XVC2.4 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Non_responder | 0 | Pre-treatment | T1 | GPL6104 | Illumina | ER+/HER2- Low Prolif | Normal | Claudin | 0 | -0.597455818321523 | Low | 7.19784422242668 | iC7 |
| 46 | 9088 | GSM3362427 | XVC2.6 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Non_responder | 0 | 2 weeks | T2 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Others | 1 | 0.0878511056091522 | High | 85.7152621505387 | iC8 |
| 47 | 7906 | GSM3362428 | XVC2.6 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Non_responder | 0 | 2 weeks | T2 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Others | 1 | 0.0408093571245624 | High | 87.2049326654402 | iC8 |
| 48 | 9248 | GSM3362429 | XVC2.6 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Non_responder | 0 | Pre-treatment | T1 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Others | 0 | -0.329462989840348 | High | 66.0619405968462 | iC7 |
| 49 | 5293 | GSM3362430 | XVC2.6 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Non_responder | 0 | Pre-treatment | T1 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Others | 0 | -0.414240587381542 | High | 68.5002875241628 | iC7 |
| 50 | 5276 | GSM3362431 | XVC2.7 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | 2 weeks | T2 | GPL6104 | Illumina | ER-/HER2- | Basal | Claudin | 1 | 0.134209852300862 | Intermediate | 39.1878326036422 | iC4 |
| 51 | 5040 | GSM3362432 | XVC2.7 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | 2 weeks | T2 | GPL6104 | Illumina | ER-/HER2- | Basal | Claudin | 1 | 0.0729958166140186 | Intermediate | 42.281763673053 | iC4 |
| 52 | 5315 | GSM3362433 | XVC2.7 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | ER-/HER2- | Basal | Claudin | 1 | 0.407239819004525 | High | 85.8353396004939 | iC10 |
| 53 | 7821 | GSM3362434 | XVC2.7 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | ER-/HER2- | Basal | Claudin | 1 | 0.435584393409033 | High | 91.0002838927883 | iC10 |
| 54 | 7794 | GSM3362435 | XVC2.8 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | 2 weeks | T2 | GPL6104 | Illumina | HER2+ | Her2 | Others | 1 | 0.316059079655084 | High | 73.48802074112 | iC5 |
| 55 | 7503 | GSM3362436 | XVC2.8 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | 2 weeks | T2 | GPL6104 | Illumina | HER2+ | Her2 | Others | 1 | 0.277554853581491 | High | 77.1287561122085 | iC5 |
| 56 | 8925 | GSM3362437 | XVC2.8 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | HER2+ | Her2 | Others | 1 | 0.457952702125843 | High | 82.3918282130684 | iC5 |
| 57 | 6182 | GSM3362438 | XVC2.8 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | HER2+ | Her2 | Others | 1 | 0.498847434474515 | High | 93.7646475525101 | iC5 |
| 58 | 5751 | GSM3362439 | XVC2.9 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Non_responder | 0 | 2 weeks | T2 | GPL6104 | Illumina | ER+/HER2- Low Prolif | LumA | Claudin | 0 | -0.41765559634594 | Low | 17.5755055559223 | iC4 |
| 59 | 8280 | GSM3362440 | XVC2.9 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Non_responder | 0 | 2 weeks | T2 | GPL6104 | Illumina | ER+/HER2- Low Prolif | LumA | Claudin | 1 | -0.288824383164006 | Low | 23.7491649856093 | iC4 |
| 60 | 5373 | GSM3362441 | XVC2.9 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Non_responder | 0 | Pre-treatment | T1 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumA | Others | 0 | -0.485016648168701 | Intermediate | 29.4973887189495 | iC7 |
| 61 | 9994 | GSM3362442 | XVC2.9 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Non_responder | 0 | Pre-treatment | T1 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Others | 1 | -0.274908221634082 | Intermediate | 32.753359788031 | iC7 |
| 62 | 7081 | GSM3362443 | XVC2.10 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Non_responder | 0 | 2 weeks | T2 | GPL6104 | Illumina | ER+/HER2- Low Prolif | LumA | Claudin | 0 | -0.526509007086144 | Low | 13.8795732925156 | iC3 |
| 63 | 9611 | GSM3362444 | XVC2.10 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Non_responder | 0 | 2 weeks | T2 | GPL6104 | Illumina | ER+/HER2- Low Prolif | LumA | Claudin | 0 | -0.564159480918637 | Low | 7.9118531452787 | iC3 |
| 64 | 9108 | GSM3362445 | XVC2.10 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Non_responder | 0 | Pre-treatment | T1 | GPL6104 | Illumina | ER+/HER2- Low Prolif | LumA | Claudin | 0 | -0.55826859045505 | Low | 23.7782159815662 | iC3 |
| 65 | 7116 | GSM3362446 | XVC2.10 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Non_responder | 0 | Pre-treatment | T1 | GPL6104 | Illumina | ER+/HER2- Low Prolif | LumA | Claudin | 0 | -0.638862802014855 | Low | 21.5370930379127 | iC3 |
| 66 | 5754 | GSM3362447 | XVC2.11 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | 2 weeks | T2 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Claudin | 0 | -0.342952275249722 | High | 67.6581314302564 | iC4 |
| 67 | 6005 | GSM3362448 | XVC2.11 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | 2 weeks | T2 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Claudin | 1 | -0.229061726287032 | High | 73.5958322150045 | iC4 |
| 68 | 7584 | GSM3362449 | XVC2.11 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Others | 1 | -0.146674635020917 | High | 92.6465069970131 | iC6 |
| 69 | 7338 | GSM3362450 | XVC2.11 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Others | 1 | -0.178178092717493 | High | 95.2197796611072 | iC6 |
| 70 | 6447 | GSM3362451 | XVC2.12 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | 2 weeks | T2 | GPL6104 | Illumina | ER+/HER2- Low Prolif | LumB | Others | 0 | -0.503030820455904 | Intermediate | 35.4854445633563 | iC8 |
| 71 | 8951 | GSM3362452 | XVC2.12 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | 2 weeks | T2 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Others | 0 | -0.486297276530351 | Intermediate | 38.64554734578 | iC8 |
| 72 | 8357 | GSM3362453 | XVC2.12 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Others | 1 | -0.216426193118757 | High | 86.0309496399371 | iC4 |
| 73 | 8979 | GSM3362454 | XVC2.12 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Others | 1 | -0.197985144711005 | High | 96.0225555160498 | iC4 |
| 74 | 9766 | GSM3362455 | XVC2.14 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | 2 weeks | T2 | GPL6104 | Illumina | ER+/HER2- Low Prolif | LumA | Others | 1 | -0.203022282933493 | Intermediate | 42.4999689315738 | iC8 |
| 75 | 6133 | GSM3362456 | XVC2.14 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | 2 weeks | T2 | GPL6104 | Illumina | ER+/HER2- Low Prolif | LumB | Others | 0 | -0.30342354648681 | Intermediate | 50.8079081975616 | iC8 |
| 76 | 8229 | GSM3362457 | XVC2.14 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Claudin | 1 | 0.037308972936054 | Intermediate | 49.3702066865386 | iC3 |
| 77 | 6933 | GSM3362458 | XVC2.14 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Claudin | 1 | 0.0102450268931956 | Intermediate | 52.7078433331434 | iC3 |
| 78 | 6500 | GSM3362459 | XVC2.15 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | 2 weeks | T2 | GPL6104 | Illumina | ER-/HER2- | Her2 | Claudin | 1 | 0.0664219243575514 | High | 62.0190103261765 | iC4 |
| 79 | 9575 | GSM3362460 | XVC2.15 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | 2 weeks | T2 | GPL6104 | Illumina | ER-/HER2- | Her2 | Claudin | 1 | 0.0548108938785964 | High | 63.8524509599014 | iC4 |
| 80 | 8782 | GSM3362461 | XVC2.15 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | ER-/HER2- | Her2 | Claudin | 1 | 0.346196533765901 | High | 80.5422481371452 | iC5 |
| 81 | 6913 | GSM3362462 | XVC2.15 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | ER-/HER2- | Her2 | Claudin | 1 | 0.236916246905148 | High | 72.5809840895765 | iC5 |
| 82 | 6108 | GSM3362463 | XVC2.16 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | 2 weeks | T2 | GPL6104 | Illumina | ER-/HER2- | Normal | Claudin | 1 | -0.108597285067873 | Low | 15.7885465157284 | iC4 |
| 83 | 9260 | GSM3362464 | XVC2.16 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | 2 weeks | T2 | GPL6104 | Illumina | ER-/HER2- | Normal | Claudin | 1 | -0.016392043029113 | Low | 18.808881728715 | iC4 |
| 84 | 6074 | GSM3362465 | XVC2.16 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | ER-/HER2- | Normal | Claudin | 1 | -0.223085460599334 | Low | 0.0 | iC4 |
| 85 | 8145 | GSM3362466 | XVC2.16 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | ER-/HER2- | Normal | Claudin | 1 | -0.215060189532997 | Low | 0.0 | iC4 |
| 86 | 6385 | GSM3362467 | XVC2.19 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | 2 weeks | T2 | GPL6104 | Illumina | ER-/HER2- | Basal | Claudin | 1 | 0.230683855545121 | High | 62.4073253054672 | iC4 |
| 87 | 7283 | GSM3362468 | XVC2.19 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | 2 weeks | T2 | GPL6104 | Illumina | ER-/HER2- | Basal | Claudin | 1 | 0.27832323059848 | High | 97.3143564696003 | iC10 |
| 88 | 9705 | GSM3362469 | XVC2.19 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | ER-/HER2- | Basal | Claudin | 1 | 0.480406386066763 | High | 76.0735593812848 | iC10 |
| 89 | 7377 | GSM3362470 | XVC2.19 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | ER-/HER2- | Basal | Claudin | 1 | 0.496115427302997 | High | 82.7924091684298 | iC10 |
| 90 | 9222 | GSM3362471 | XVC2.20 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | ER+/HER2- Low Prolif | LumB | Others | 0 | -0.498762059250406 | Intermediate | 52.9257258028202 | iC8 |
| 91 | 9043 | GSM3362472 | XVC2.20 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | ER+/HER2- Low Prolif | LumB | Others | 0 | -0.466490224536839 | Intermediate | 49.9454164064854 | iC8 |
| 92 | 7259 | GSM3362473 | XVC2.21 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | 2 weeks | T2 | GPL6104 | Illumina | HER2+ | LumB | Claudin | 1 | 0.0632630410654828 | High | 53.4467069969808 | iC4 |
| 93 | 5685 | GSM3362474 | XVC2.21 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | 2 weeks | T2 | GPL6104 | Illumina | HER2+ | Her2 | Claudin | 1 | 0.0292837018697174 | High | 68.4234637792989 | iC4 |
| 94 | 8856 | GSM3362475 | XVC2.21 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | HER2+ | LumB | Others | 1 | 0.388713395372663 | High | 100.0 | iC5 |
| 95 | 5846 | GSM3362476 | XVC2.21 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | HER2+ | LumB | Others | 1 | 0.391360027320072 | High | 100.0 | iC5 |
| 96 | 5982 | GSM3362477 | XVC2.22 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | 2 weeks | T2 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Others | 1 | 0.062836164944933 | High | 72.3989311815799 | iC2 |
| 97 | 9714 | GSM3362478 | XVC2.22 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | 2 weeks | T2 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Others | 1 | 0.0225390591650303 | High | 69.2937025026303 | iC2 |
| 98 | 9572 | GSM3362479 | XVC2.22 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Others | 1 | -0.105779902672245 | High | 79.0474130007403 | iC2 |
| 99 | 5150 | GSM3362480 | XVC2.22 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Responder | 1 | Pre-treatment | T1 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Others | 1 | -0.0320157090412362 | High | 72.4983501455213 | iC2 |
| 100 | 6637 | GSM3362481 | XVC2.23 | XVC2 | Chemotherapy | 1 | 1 | 0 | Ki67% drop | Non_responder | 0 | 2 weeks | T2 | GPL6104 | Illumina | ER+/HER2- High Prolif | LumB | Others | 1 | -0.13864936395458 | High | 73.5522557210691 | iC8 |